Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Ipsilateral breast tumour recurrence in hereditary breast cancer following breast-conserving therapy.

European journal of cancer (Oxford, England : 1990) - 1 May 2004

Seynaeve C, Verhoog L C, van de Bosch L M C, van Geel A N, Menke-Pluymers M, Meijers-Heijboer E J, van den Ouweland A M W, Wagner A, Creutzberg C L, Niermeijer M F, Klijn J G M, Brekelmans C T M

Abstract excerpt

The overall rate of an ipsilateral breast tumour recurrence (IBTR) after breast-conserving therapy (BCT) ranges from 1% to 2% per year. Risk factors include young age but data on the impact of BRCA1/2 mutations or a definite positive family history for breast cancer are scarce. We investigated IBTR after BCT in patients with hereditary breast cancer (HBC). Through our family cancer clinic we identified 87 HBC...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Cohort Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease-Free Survival

Share to Genes, BRCA1

Share to Genes, BRCA2

Share to Neoplasm Recurrence, Local

Share to Neoplasms, Second Primary

Share to Proportional Hazards Models

Source

Identifiers

PMID: 15110878
DOI: 10.1016/j.ejca.2004.01.017

Genes

BRCA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Ipsilateral breast tumour recurrence in hereditary breast cancer following breast-conserving therapy.PMID 15110878Read ↗

Family history of breast cancer and local recurrence after breast-conserving therapy. The Dutch Study Group on Local Recurrence after Breast Conservation (BORST).Semantic proximity Read ↗

Does breast-conserving surgery with radiotherapy in BRCA-mutation carriers significantly increase ipsilateral breast tumor recurrence? A systematic review and meta-analysis.Semantic proximity Read ↗

Impact of BRCA1/2 pathogenic variants on ipsilateral breast tumor recurrence and prognosis following breast-conserving surgery.Semantic proximity Read ↗

Hereditary breast cancer: clinical features and risk reduction strategies.Semantic proximity Read ↗

Contralateral breast cancer and tumor recurrence in BRCA1/2 carriers and non-carriers at a high risk of hereditary breast cancer after bilateral mastectomy.Semantic proximity Read ↗

Surgical management of breast cancer in BRCA-mutation carriers: a systematic review and meta-analysis.Semantic proximity Read ↗

High risk of contralateral breast carcinoma in women with hereditary/familial non-BRCA1/BRCA2 breast carcinoma.Semantic proximity Read ↗

Long-term effects of first degree family history of breast cancer in young women: Recurrences and bilateral breast cancer.Semantic proximity Read ↗

Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status.Semantic proximity Read ↗

Cumulative risk of second primary contralateral breast cancer in BRCA1/BRCA2 mutation carriers with a first breast cancer: A systematic review and meta-analysis.Semantic proximity Read ↗

High risk of in-breast tumor recurrence after BRCA1/2-associated breast cancer.Semantic proximity Read ↗

Prognostic Impact of Breast-Conserving Therapy Versus Mastectomy of BRCA1/2 Mutation Carriers Compared With Noncarriers in a Consecutive Series of Young Breast Cancer Patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.